Amneal Pharmaceuticals, Inc. (AMRX) Operating Margin % [USD] 2018 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Amneal Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from 2018 to 2024.
  • Amneal Pharmaceuticals, Inc. Operating Margin for the quarter ending March 31, 2024 was 6.38 %.
  • Amneal Pharmaceuticals, Inc. annual Operating Margin for 2023 was 8.54 %.
  • Amneal Pharmaceuticals, Inc. annual Operating Margin for 2022 was -4.29 %, a 159% decline from 2021.
  • Amneal Pharmaceuticals, Inc. annual Operating Margin for 2021 was 7.29 %, a 59.5% increase from 2020.
Operating Margin, Quarterly (% [USD])
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 6.38 +10.1 Jan 1, 2024 Mar 31, 2024
Q4 2023 8.54 +12.8 Oct 1, 2023 Dec 31, 2023
Q3 2023 9.48 +15.1 Jul 1, 2023 Sep 30, 2023
Q2 2023 8.43 +14.8 Apr 1, 2023 Jun 30, 2023
Q1 2023 -3.69 -9.89 -159% Jan 1, 2023 Mar 31, 2023
Q4 2022 -4.29 -11.6 -159% Oct 1, 2022 Dec 31, 2022
Q3 2022 -5.6 -13.4 -172% Jul 1, 2022 Sep 30, 2022
Q2 2022 -6.39 -13 -197% Apr 1, 2022 Jun 30, 2022
Q1 2022 6.2 +2.21 +55.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 7.29 +2.72 +59.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 7.82 +5.28 +207% Jul 1, 2021 Sep 30, 2021
Q2 2021 6.59 +10.4 Apr 1, 2021 Jun 30, 2021
Q1 2021 3.99 +9.74 Jan 1, 2021 Mar 31, 2021
Q4 2020 4.57 +19.9 Oct 1, 2020 Dec 31, 2020
Q3 2020 2.55 +14.3 Jul 1, 2020 Sep 30, 2020
Q2 2020 -3.85 -3 -355% Apr 1, 2020 Jun 30, 2020
Q1 2020 -5.75 +3.93 +40.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -15.3 -14.1 -1193% Oct 1, 2019 Dec 31, 2019
Q3 2019 -11.7 Jul 1, 2019 Sep 30, 2019
Q2 2019 -0.85 Apr 1, 2019 Jun 30, 2019
Q1 2019 -9.68 Jan 1, 2019 Mar 31, 2019
Q4 2018 -1.18 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.